ASHBURN, Va.–(BUSINESS WIRE)–I2Pure, a leader in molecular iodine technology, today celebrates Zimmer Biomet’s recent achievement in receiving Japan’s Pharmaceutical and Medical Devices Agency (PMDA) approval for orthopedic implants utilizing iodine technology to inhibit bacterial adhesion on implant surfaces. This milestone represents further validation of molecular iodine’s therapeutic potential in advanced medical applications. “We could not be more pleased to see Zimmer Biomet and the Jap